Michael W Riggs

Animal and Comparative Sciences

Phone(520) 621-8445
Emailmriggs@u.arizona.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Michael W Riggs is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Finished

IMMUNOTHERAPY OF CRYPTOSPORIDIOSIS USING MONOCLONALS
Sterling, C. R., Riggs, M. W., Cama, V., Enriquez, F. J. & Perryman, L.
National Institutes of Health
7/1/90 → 5/31/99
Project: Research project

1443 Citations
24 h-Index
44 Article
3 Review article
2 Chapter
1 Comment/debate

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
Van Voorhis, W. C., Hulverson, M. A., Choi, R., Huang, W., Arnold, S. L. M., Schaefer, D. A., Betzer, D. P., Vidadala, R. S. R., Lee, S., Whitman, G. R., Barrett, L. K., Maly, D. J., Riggs, M. W., Fan, E., Kennedy, T. J., Tzipori, S., Doggett, J. S., Winzer, P., Anghel, N., Imhof, D. & 6 others, Müller, J., Hemphill, A., Ferre, I., Sanchez-Sanchez, R., Ortega-Mora, L. M. & Ojo, K. K., Jan 2021, In: Veterinary Parasitology. 289, 109336.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
A symbiotic bacterium of shipworms produces a compound with broad spectrum anti-apicomplexan activity
O’Connor, R. M., Nepveux, F. J. V., Abenoja, J., Bowden, G., Reis, P., Beaushaw, J., Bone Relat, R. M., Driskell, I., Gimenez, F., Riggs, M. W., Schaefer, D. A., Schmidt, E. W., Lin, Z., Distel, D. L., Clardy, J., Ramadhar, T. R., Allred, D. R., Fritz, H. M., Rathod, P., Chery, L. & 1 others, White, J., May 2020, In: PLoS pathogens. 16, 5, e1008600.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned
Choi, R., Hulverson, M. A., Huang, W., Vidadala, R. S. R., Whitman, G. R., Barrett, L. K., Schaefer, D. A., Betzer, D. P., Riggs, M. W., Doggett, J. S., Hemphill, A., Ortega-Mora, L. M., McCloskey, M. C., Arnold, S. L. M., Hackman, R. C., Marsh, K. C., Lynch, J. J., Freiberg, G. M., Leroy, B. E., Kempf, D. J. & 6 others, Choy, R. K. M., de Hostos, E. L., Maly, D. J., Fan, E., Ojo, K. K. & Van Voorhis, W. C., May 2020, In: International Journal for Parasitology. 50, 5, p. 413-422 10 p.
Research output: Contribution to journal › Review article › peer-review
12 Scopus citations
Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics
Riggs, M. W. & Schaefer, D. A., 2020, Methods in Molecular Biology. Humana Press Inc., p. 253-282 30 p. (Methods in Molecular Biology; vol. 2052).
Research output: Chapter in Book/Report/Conference proceeding › Chapter
4 Scopus citations
Neonatal mouse gut metabolites influence cryptosporidium parvum infection in intestinal epithelial cells
Vandussen, K. L., Funkhouser-Jones, L. J., Akey, M. E., Schaefer, D. A., Ackman, K., Riggs, M. W., Stappenbeck, T. S. & David Sibley, L., Nov 1 2020, In: mBio. 11, 6, p. 1-16 16 p., e02582-20.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations

IMMUNOTHERAPY OF CRYPTOSPORIDIOSIS USING MONOCLONALS

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases

A symbiotic bacterium of shipworms produces a compound with broad spectrum anti-apicomplexan activity

Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned

Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics

Neonatal mouse gut metabolites influence cryptosporidium parvum infection in intestinal epithelial cells